CRWD Stock Cash Flow Statements

CrowdStrike Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

CrowdStrike Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31	2021-10-31	2021-07-31	2021-04-30	2021-01-31	2020-10-31	2020-07-31	2020-04-30	2020-01-31	2019-10-31	2019-07-31	2019-04-30

operating activities
net income	-77,645,000	-110,993,000	-92,731,000	-16,819,000	46,690,000	46,264,000	54,941,000	26,669,000	8,476,000	499,000	-48,932,000	-54,631,000	-48,313,000	-30,409,000	-41,739,000	-50,450,000	-57,318,000	-82,871,000	-19,002,000	-24,531,000	-29,874,000	-19,222,000	-28,408,000	-35,505,000	-51,889,000	-25,977,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	60,411,000	56,423,000	50,101,000	48,915,000	46,247,000	42,689,000	36,866,000	33,788,000	29,775,000	26,409,000	23,623,000	19,476,000	17,805,000	16,341,000	16,661,000	14,522,000	12,770,000	11,955,000	10,967,000	10,107,000	9,419,000	8,202,000	7,003,000	5,830,000	5,320,000	4,873,000
amortization of intangible assets	7,627,000	7,634,000	7,339,000	6,333,000	6,337,000	5,995,000	5,503,000	4,637,000	4,102,000	4,174,000	4,227,000	4,146,000	4,104,000	4,088,000	3,830,000	3,337,000	3,318,000	2,417,000	869,000	372,000	104,000	103,000	102,000	100,000	139,000	146,000
amortization of deferred contract acquisition costs	107,038,000	102,903,000	91,124,000	79,862,000	73,723,000	74,128,000	65,743,000	60,281,000	57,555,000	55,322,000	49,258,000	43,996,000	39,962,000	37,592,000	34,172,000	29,293,000	26,043,000	24,376,000	21,485,000	16,769,000	14,720,000	13,451,000	11,334,000	9,049,000	7,731,000	7,345,000
non-cash operating lease cost	4,531,000	4,186,000	4,183,000	3,933,000	3,795,000	3,372,000	3,673,000	3,394,000	3,239,000	3,092,000	2,622,000	2,294,000	2,287,000	2,237,000	2,376,000	2,258,000	2,289,000	2,180,000	120,000	2,727,000	2,656,000	2,283,000
stock-based compensation expense	287,153,000	253,604,000	272,531,000	208,888,000	200,877,000	183,125,000	176,272,000	159,614,000	164,777,000	130,856,000	152,347,000	140,113,000	131,550,000	102,494,000	92,637,000	86,666,000	76,287,000	54,362,000	47,714,000	40,610,000	37,713,000	23,638,000	24,363,000	21,966,000	29,859,000	3,752,000
deferred income taxes	-639,000	-1,681,000	-7,781,000	-193,000	-1,674,000	-255,000	-1,032,000	-2,003,000	-97,000	-255,000	-980,000	682,000	-148,000	1,752,000
realized gains on strategic investments			-94,000	0	654,000	-6,881,000
non-cash interest expense	1,205,000	1,088,000	1,015,000	963,000	911,000	874,000	836,000	806,000	777,000	754,000	736,000	711,000	697,000	669,000	645,000	625,000	604,000	595,000	347,000	186,000	169,000	151,000	142,000	130,000
change in fair value of strategic investments	0	1,579,000									2,927,000	-629,000	-1,920,000	-2,208,000	-467,000	0	0	-4,356,000
accretion of short-term investments purchased at a discount			0	0	0	2,285,000	-351,000
changes in operating assets and liabilities, net of impact of acquisitions
accounts receivable	-77,863,000	319,871,000	-313,403,000	-152,876,000	41,811,000	150,249,000	-283,557,000	-20,860,000	-78,371,000	165,089,000	-140,869,000	-66,512,000	-49,670,000	-1,058,000	-84,710,000	-16,387,000	-55,723,000	31,466,000	-66,323,000	-22,175,000	-4,631,000	20,651,000	-19,436,000	-30,829,000	-28,177,000	5,375,000
deferred contract acquisition costs	-148,819,000	-102,803,000	-223,072,000	-203,079,000	-91,853,000	-66,480,000	-164,971,000	-84,671,000	-72,475,000	-49,532,000	-115,451,000	-74,325,000	-57,586,000	-51,354,000	-82,407,000	-64,325,000	-51,176,000	-36,400,000	-66,234,000	-35,753,000	-26,425,000	-22,563,000	-31,356,000	-27,450,000	-19,317,000	-8,471,000
prepaid expenses and other assets	-29,416,000	-20,995,000	-147,400,000	20,392,000	-34,622,000	-28,602,000	-80,548,000	4,366,000	-17,796,000	-8,542,000	-32,686,000	-3,183,000	-15,181,000	4,243,000	-19,747,000	38,095,000	-47,114,000	-769,000	-284,000	3,440,000	-7,285,000	5,332,000	-23,584,000	-7,378,000	-8,456,000	-4,049,000
accounts payable	69,918,000	-83,228,000	50,843,000	34,168,000	-348,000	276,000	-21,259,000	5,343,000	15,614,000	-18,596,000	-40,470,000	24,213,000	37,225,000	-36,431,000	40,281,000	-12,416,000	15,945,000	-10,562,000	4,769,000	-3,078,000	4,898,000	4,736,000	-2,797,000	2,124,000	-8,715,000	2,818,000
accrued expenses and other liabilities	56,479,000	-43,763,000	132,851,000	77,699,000	24,597,000	-16,629,000	-19,011,000	28,662,000	41,511,000	-36,576,000	37,103,000	16,097,000	13,023,000	-7,300,000
accrued payroll and benefits	12,917,000	-37,848,000	-4,023,000	119,328,000	-11,740,000	-17,692,000	63,292,000	31,971,000	-12,880,000	-17,281,000	43,591,000	21,390,000	-12,990,000	13,235,000	10,423,000	-595,000	16,884,000	5,969,000	14,500,000	19,423,000	-1,359,000	648,000	-95,000	16,848,000	7,374,000	-6,601,000
operating lease liabilities	-3,527,000	-4,586,000	-3,845,000	-4,699,000	-2,582,000	-4,531,000	2,112,000	-9,672,000	-3,276,000	-3,199,000	-3,327,000	-2,333,000	-2,494,000	-2,210,000	-2,506,000	-2,372,000	-2,467,000	-2,555,000	-6,671,000	-2,749,000	4,290,000	-2,975,000
deferred revenue	63,462,000	42,716,000	527,084,000	103,321,000	23,818,000	15,041,000	510,984,000	33,127,000	103,850,000	48,678,000	339,574,000	171,346,000	151,555,000	163,276,000	240,826,000	123,840,000	142,366,000	109,376,000	149,221,000	70,910,000	53,867,000	64,805,000	123,529,000	77,877,000	54,550,000	24,812,000
net cash from operating activities	332,832,000	384,107,000	345,722,000	326,136,000	326,641,000	383,228,000	347,016,000	273,518,000	244,781,000	300,892,000	273,293,000	242,851,000	209,906,000	214,957,000	159,718,000	159,058,000	108,475,000	147,533,000	114,463,000	88,501,000	55,025,000	98,577,000	66,107,000	38,635,000	-6,214,000	1,415,000
capex	-47,786,000	-103,188,000	-104,914,000	-94,975,000	-53,770,000	-60,162,000	-63,436,000	-33,894,000	-55,490,000	-73,166,000	-63,766,000	-68,774,000	-74,149,000	-57,425,000	-26,723,000	-35,555,000	-34,836,000	-30,230,000	-17,073,000	-12,406,000	-22,608,000	-11,576,000	-15,431,000	-31,587,000	-22,944,000	-17,525,000
free cash flows	285,046,000	280,919,000	240,808,000	231,161,000	272,871,000	323,066,000	283,580,000	239,624,000	189,291,000	227,726,000	209,527,000	174,077,000	135,757,000	157,532,000	132,995,000	123,503,000	73,639,000	117,303,000	97,390,000	76,095,000	32,417,000	87,001,000	50,676,000	7,048,000	-29,158,000	-16,110,000
investing activities
purchases of property and equipment	-30,497,000	-85,751,000	-87,211,000	-78,704,000	-39,254,000	-49,683,000	-52,584,000	-21,264,000	-40,417,000	-62,264,000	-55,410,000	-61,270,000	-66,128,000	-52,211,000	-26,723,000	-29,627,000	-29,997,000	-25,796,000	-12,554,000	-9,911,000	-20,640,000	-9,694,000	-13,350,000	-29,689,000	-21,618,000	-15,541,000
capitalized internal-use software and website development costs	-17,289,000	-17,437,000	-17,703,000	-16,271,000	-14,516,000	-10,479,000	-10,852,000	-12,630,000	-15,073,000	-10,902,000	-8,356,000	-7,504,000	-8,021,000	-5,214,000
purchases of strategic investments	-1,043,000	-374,000	-7,000,000	-10,000,000	-1,044,000	-1,658,000	-5,000,000	0	-1,664,000	-10,513,000
proceeds from sales of strategic investments	1,242,000	3,146,000	1,612,000	0	488,000	10,407,000
business acquisitions, net of cash acquired			-213,876,000	0	-5,000	-96,376,000	-281,000				115,000				-60,772,000
proceeds from maturities and sales of short-term investments			0	0	0	97,300,000	98,281,000	0
purchases of deferred compensation investments	-1,311,000	-1,459,000	-906,000	-606,000	-600,000	-609,000	-569,000	-586,000	-586,000	-290,000
proceeds from sales of deferred compensation investments	119,000	45,000		0
net cash from investing activities	-48,779,000	-101,830,000	-325,019,000	-105,581,000	-54,890,000	-51,098,000	20,395,000	-468,836,000	41,760,000	66,031,000	-319,140,000	-97,419,000	-79,149,000	-60,950,000	-93,660,000	-44,735,000	-41,175,000	-384,946,000	-17,301,000	-98,375,000	-23,608,000	634,711,000	-572,115,000	-27,262,000	-34,392,000	4,138,000
financing activities
proceeds from the issuance of common stock upon exercise stock options	1,721,000	634,000		844,000	1,641,000	823,000
proceeds from issuance of common stock under the employee stock purchase plan			43,517,000	0			30,943,000	0			24,974,000	0			22,825,000	0			16,979,000	0
distributions to non-controlling interest holders			-806,000	0	-244,000	-3,841,000
capital contributions from non-controlling interest holders	0	1,500,000	3,000,000	0	5,000,000	500,000	0	0	2,831,000	5,257,000	1,901,000	5,090,000	2,501,000	1,462,000	250,000	4,250,000	3,000,000	655,000	0	250,000	50,000	500,000
net cash from financing activities	74,187,000	2,134,000	46,386,000	844,000	62,496,000	-2,518,000	33,460,000	2,053,000	49,737,000	7,908,000	29,134,000	4,976,000	38,759,000	4,568,000	26,178,000	7,554,000	36,190,000	2,609,000	760,529,000	5,171,000	27,542,000	6,893,000	27,310,000	-968,000	680,684,000	-882,000
effect of foreign exchange rates on cash, cash equivalents and restricted cash	49,000	6,546,000	-4,637,000	399,000	877,000	-1,917,000	5,369,000	-4,494,000	1,273,000	-190,000	5,579,000	-2,744,000
net increase in cash, cash equivalents and restricted cash	358,289,000	290,957,000	62,452,000	221,798,000	335,124,000	327,695,000	406,240,000	-197,759,000	337,551,000	374,641,000	-11,134,000	147,664,000
cash, cash equivalents and restricted cash at beginning of period	0	4,324,666,000	0	0	0	3,377,597,000	0	0	0	2,456,924,000	0	0
cash, cash equivalents and restricted cash at end of period	358,289,000	4,615,623,000	62,452,000	221,798,000	335,124,000	3,705,292,000	406,240,000	-197,759,000	337,551,000	2,831,565,000	-11,134,000	147,664,000
cash, cash equivalents and restricted cash at the end of period:
cash and cash equivalents	358,283,000	4,614,153,000	62,971,000	221,788,000	336,099,000	3,702,437,000	406,197,000	-198,343,000	337,538,000	2,829,677,000	-11,182,000	147,693,000
restricted cash included in prepaid expenses and other assets	6,000	1,470,000	-519,000	10,000	-975,000	2,855,000	43,000	584,000	13,000	1,888,000	48,000	-29,000
total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	358,289,000	4,615,623,000		221,798,000	335,124,000	3,705,292,000		-197,759,000	337,551,000	2,831,565,000		147,664,000
supplemental disclosure of cash flow information:
interest paid	0	11,250,000	0	11,250,000	0	11,250,000	0	11,250,000	0	11,250,000	4,000	11,258,000	24,000	11,265,000	40,000	157,000	67,000	11,000	14,000				4,000	1,000	1,000	1,000
income taxes paid, net of refunds received	9,005,000	17,026,000	4,827,000	3,945,000	2,656,000	7,594,000	4,697,000	7,920,000	6,614,000	3,377,000	5,174,000	1,802,000	1,019,000	3,948,000	70,823,000	1,517,000	952,000	1,385,000	169,000	900,000
supplemental disclosure of non-cash investing and financing activities:
net increase in property and equipment included in accounts payable and accrued expenses			-13,359,000				2,785,000	14,223,000	2,390,000	-22,479,000	9,150,000	-5,539,000	5,645,000	13,165,000	-544,000	2,586,000	186,000	4,294,000	-3,713,000	5,775,000	-297,000	-723,000	-2,478,000	-4,535,000
equity consideration for acquisitions			687,000	0	0	468,000	0				0				0	0	0	4,011,000	0
operating lease liabilities arising from obtaining operating right-of-use assets				4,155,000	1,095,000	1,759,000
proceeds from sales of strategic investments not yet received	-1,185,000	1,846,000	184,000	0	74,000	4,734,000
stock-based compensation included in capitalized software development costs and fixed assets	15,140,000	13,291,000	5,025,000	12,456,000	11,512,000	7,966,000
noncash consideration for the purchase of strategic investments			0	0	0	3,319,000
noncash consideration received from sales of strategic investments			0	0	0	3,319,000
net decrease in property and equipment included in accounts payable and accrued expenses		-32,212,000			1,186,000	-17,655,000
purchases of intangible assets							-10,600,000	-26,000
purchases of short-term investments							0
proceeds from the sale of deferred compensation investments
repayment of loan payable											0
proceeds from issuance of common stock upon exercise of stock options							2,517,000	2,053,000	1,474,000	2,651,000	2,259,000	1,477,000	1,813,000	3,106,000	3,103,000	3,304,000	5,738,000	3,754,000	7,309,000	4,921,000	10,208,000	6,393,000	12,162,000	824,000	7,016,000	1,510,000
total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows
vesting of early exercised stock options											0	734,000	735,000	735,000	776,000	795,000	797,000	797,000	797,000	799,000	849,000	873,000
operating lease liabilities arising from obtaining operating right of-use assets									-764,000	13,847,000	16,762,000	-428,000			276,000	1,470,000	530,000	2,591,000
purchases of intangible assets included in accrued expenses and other liabilities									-474,000	500,000
payments of debt issuance costs related to revolving line of credit
payments of debt issuance costs related to senior notes
proceeds from sales of investments										150,000,000
gain on sale of debt securities																				0	0	-1,347,000
amortization of marketable securities purchased at a premium
purchases of investments
maturities of marketable securities																			0	0	0	91,605,000	31,212,000	74,450,000	54,319,000	68,995,000
proceeds from issuance of senior notes, net of debt financing costs
debt financing costs, accrued but not paid
purchase of strategic investments												-10,181,000	-5,000,000	-2,825,000		-8,500,000	-6,000,000	-1,309,000	0	-500,000
purchase of intangible assets												0	0	-700,000
payment of debt issuance costs related to revolving line of credit																0	0	-219,000
payment of debt issuance costs related to senior notes																0	0	-1,581,000
effect of foreign exchange rates on cash and cash equivalents														-2,472,000	-3,111,000	-1,420,000	-1,436,000	1,193,000	991,000	-105,000	784,000	12,000	-109,000	392,000	-263,000	-86,000
net increase in cash and cash equivalents														156,103,000	89,125,000	120,457,000	102,054,000	-233,611,000	858,682,000	-4,808,000	59,743,000	740,193,000	-478,807,000	10,797,000	639,815,000	4,585,000
cash and cash equivalents, beginning of period														1,996,633,000	0	0	0	1,918,608,000	0	0	0	264,798,000	0	0	0	88,408,000
cash and cash equivalents, end of period														2,152,736,000	89,125,000	120,457,000	102,054,000	1,684,997,000	858,682,000	-4,808,000	59,743,000	1,004,991,000	-478,807,000	10,797,000	639,815,000	92,993,000
change in fair value of redeemable convertible preferred stock warrant liability																							0	0	4,855,000	1,167,000
amortization
other non-cash charges
purchases of marketable securities																			0	0	0	-84,904,000	-592,004,000	-70,125,000	-65,767,000	-51,805,000
proceeds from sales of marketable securities																			0	0	0	639,586,000	5,108,000	0	0	4,473,000
proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts																							0	0
payments of deferred offering costs																							0	-1,792,000	-1,688,000	-2,392,000
proceeds from the issuance of common stock upon exercise of early exercisable stock options																							0	0
settlement related to stockholder short-swing trade profit
conversion of redeemable convertible preferred stock to common stock																							0	-101,295,000
conversion of redeemable convertible preferred stock warrant liabilities reclassified to additional paid-in capital																							0	0
net decrease in deferred offering costs, accrued but not paid
loss on disposal of property and equipment																15,000
accrued expenses and other current liabilities																26,584,000	26,013,000	29,229,000	22,195,000	9,755,000	-7,017,000	-1,095,000	5,768,000	5,500,000	312,000	-2,407,000
other liabilities, noncurrent																							-240,000	335,000	-216,000	-177,000
capitalized internal-use software and website development																-5,928,000	-4,839,000	-4,434,000
benefit from credit losses
accretion of marketable securities purchased at a premium
changes in operating assets and liabilities, net of impact of acquisition
other liabilities																	-551,000	12,828,000	871,000	2,667,000	4,198,000	1,052,000
business acquisition, net of cash acquired																	-339,000	-353,407,000	-48,000
loss on disposal of fixed assets																		19,000
benefit from bad debts																		274,000	-96,000	-179,000	-418,000	149,000
changes in operating assets and liabilities
gain on debt and equity securities
accretion
capitalized internal-use software																			-4,519,000	-2,495,000	-1,968,000	-1,882,000	-2,081,000	-1,898,000	-1,326,000	-1,984,000
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
proceeds from revolving line of credit
issuance costs related to revolving line of credit
repayment of revolving line of credit
repayment of notes receivable from related parties
payments of contingent consideration
payments of indemnity holdback
repurchase of stock options
contingent consideration associated with business combinations
net increase in deferred offering costs, accrued but not paid																							0
accretion (amortization) of marketable securities purchased at a discount																				0
amortization (accretion) of marketable securities purchased at a discount																						578,000
income taxes paid																						353,000	808,000	641,000	299,000	114,000
accretion of marketable securities purchased at a discount																							66,000	-353,000	-447,000	-513,000
changes in operating assets and liabilities, net of business combinations
business combinations, net of cash acquired
acquisition of intangible assets
issuance of notes receivable to related parties
indemnity holdback consideration associated with business combinations
accretion of redeemable convertible preferred stock
allowance for doubtful accounts																								391,000	276,000	-254,000
proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs

other																										-424,000
net change in deferred offering costs, accrued but not paid																										-1,210,000
net change in property and equipment included in accounts payable and accrued expenses																										-54,000

We provide you with 20 years of cash flow statements for CrowdStrike stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CrowdStrike stock. Explore the full financial landscape of CrowdStrike stock with our expertly curated income statements.

The information provided in this report about CrowdStrike stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.